"Accelerating the Next Generation of Immune Medicine with Cellular Proteomics"
Join our webinar to discuss the IsoPlexis product suite capabilities and how it’s cellular proteomics and functional phenotyping is addressing urgent challenges central to unlocking the next stage of personalized cancer immunotherapies and identifying immunological mechanisms in infectious disease. With single-cell proteomics barcoding and detection of a full range of cytokines (30+) per single cell, across thousands of single cells, the IsoLight platform is showing the unique value of resolving the heterogeneity of a variety of immune cell types.
Chase Migliore, IsoPlexis, Accelerating Pre-Clinical Research With Cellular Proteomics
Nicholas Girard, IsoSpeak Software Demo
Friday, April 23 at 12:00pm to 1:00pmVirtual Event